ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01508312
Brief Title: Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma

First Submitted : January 9, 2012
First Submitted that Met QC Criteria : January 9, 2012
First Posted : January 11, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : August 28, 2018
Last Update Posted : August 31, 2018